We can’t show the full text here under this license.
Abstract
A final titre of 267 mg/L was achieved in optimized batch cultures.
- Psilocybin is a prodrug of psilocin with potential to treat mental disorders such as depression and alcohol use disorder.
- In Saccharomyces cerevisiae, deleting specific genes increased psilocybin production by fivefold.
- Functional orthologs of key genes were identified in Aspergillus nidulans, which also showed a tenfold increase in psilocybin production upon gene deletion.
- Process optimization through respiratory activity measurements improved the yield of psilocybin in batch cultures.
- The engineered A. nidulans strain may be suitable for large-scale production of psilocybin and other related pharmaceuticals.
Simplified